Hugel Pharma Co., Ltd.

Hugel Pharma Co., Ltd. was established in 2001, and started its work from the development of innovative remedy based on botulinum toxin type A. It resulted in the establishment of the botulinum toxin brand, which includes products demonstrated high efficiency as both, cosmetological and therapeutic solutions. Today, this product is accepted for treatment of at least four patological states associated with muscle spasms, and currently undergoing clinical trials as a cure for other three spasm-related pathologies. The other focus of the company is drawing towards the design of hyaluronic acid dermal fillers. The concern was able to create the state-of-art products included in the series Chaeum and Chaeum Premium, being successfully applied for rejuvenation and restoration of face skin natural beauty.